@abhishek1004.bsky.social
Many thanks. Going ahead with chemo for MM. He doesn't fulfill the SLIMCRAB criteria for frank Myeloma though. Is the diagnosis MM+AA Amyloidosis or Smouldering Myeloma+AA Amyloidosis?
April 19, 2025 at 4:53 AM
Many thanks. Going ahead with chemo for MM. He doesn't fulfill the SLIMCRAB criteria for frank Myeloma though. Is the diagnosis MM+AA Amyloidosis or Smouldering Myeloma+AA Amyloidosis?
Reposted
AL amyloid is most often assoc. with multiple myeloma. Few case studies of AA amyloid with MM. Amyloidosis associated with MM is rare and optimal treatment is not well defined. Most patients do not live more than 6 months. Chemo for MM +\- Plasma exchange?
pubmed.ncbi.nlm.nih.gov/37664311/
pubmed.ncbi.nlm.nih.gov/37664311/
Intestinal Reactive Amyloid A (AA) Amyloidosis in a Patient With Multiple Myeloma: A Case Report and Literature Review - PubMed
Amyloidosis is a rare group of disorders characterized by the extracellular deposition of misfolded protein aggregates that interfere with the function of the tissue affected. In some patients, the pr...
pubmed.ncbi.nlm.nih.gov
April 19, 2025 at 3:00 AM
AL amyloid is most often assoc. with multiple myeloma. Few case studies of AA amyloid with MM. Amyloidosis associated with MM is rare and optimal treatment is not well defined. Most patients do not live more than 6 months. Chemo for MM +\- Plasma exchange?
pubmed.ncbi.nlm.nih.gov/37664311/
pubmed.ncbi.nlm.nih.gov/37664311/
Reposted
11/10
➡️Up next - 4/28/25 on #Bluesky: Microvascular Inflammation of Kidney Allografts and Clinical Outcomes.🔬
www.nejm.org/doi/full/10.1056/NEJMoa2408835
summary by @brianrifkin.bsky.social
➡️Up next - 4/28/25 on #Bluesky: Microvascular Inflammation of Kidney Allografts and Clinical Outcomes.🔬
www.nejm.org/doi/full/10.1056/NEJMoa2408835
summary by @brianrifkin.bsky.social
Microvascular Inflammation of Kidney Allografts and Clinical Outcomes | NEJM
The heterogeneous clinical presentation of graft microvascular inflammation poses
a major challenge to successful kidney transplantation. The effect of microvascular
inflammation on allograft outco...
www.nejm.org
April 17, 2025 at 5:57 PM
11/10
➡️Up next - 4/28/25 on #Bluesky: Microvascular Inflammation of Kidney Allografts and Clinical Outcomes.🔬
www.nejm.org/doi/full/10.1056/NEJMoa2408835
summary by @brianrifkin.bsky.social
➡️Up next - 4/28/25 on #Bluesky: Microvascular Inflammation of Kidney Allografts and Clinical Outcomes.🔬
www.nejm.org/doi/full/10.1056/NEJMoa2408835
summary by @brianrifkin.bsky.social
Reposted
& the @nephjc.bsky.social summary of this study here: www.nephjc.com/news/bproad
It was a great journal club discussion too, 🤓🙏
It was a great journal club discussion too, 🤓🙏
BPROAD: Sprinting down the BP Road in Diabetes — NephJC
This week, we will discuss hopefully the final story of intensive BP lowering. BPROAD is a larger version of ACCORD without the glycemic control arm. Dive in.
www.nephjc.com
March 31, 2025 at 7:58 PM
& the @nephjc.bsky.social summary of this study here: www.nephjc.com/news/bproad
It was a great journal club discussion too, 🤓🙏
It was a great journal club discussion too, 🤓🙏